Putrescine-producing lactic acid bacteria

By employing bile acid-resistant Leviractobacillus pausiborans strains N36 and N50 in a skim milk medium with glucose, the challenges of putrescine production safety and quantity are addressed, resulting in a effective and safe method for producing this polyamine.

JP7670255B2Active Publication Date: 2025-04-30NAT AGRI & FOOD RES ORG
View PDF 7 Cites 0 Cited by

Patent Information

Application Number
JP2021084514
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Filing Date
2021-05-19
Publication Date
2025-04-30
Estimated Expiration
2041-05-19

AI Technical Summary

Technical Problem

Current methods for producing putrescine, such as chemical synthesis and extraction from natural sources, face challenges related to safety and environmental impact, while existing microorganism-based methods do not adequately address production quantity and human safety concerns.

Method used

The use of Leviractobacillus pausiborans strains N36 and N50, which are resistant to bile acids and capable of producing putrescine, in combination with a skim milk medium supplemented with glucose to enhance putrescine production.

Benefits of technology

This approach results in a safe and effective method for producing putrescine, with the lactic acid bacteria serving as probiotics and the process yielding increased putrescine production when glucose is added to the skim milk medium.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007670255000001
    Figure 0007670255000001
  • Figure 0007670255000002
    Figure 0007670255000002
  • Figure 0007670255000003
    Figure 0007670255000003
Patent Text Reader

Abstract

To provide a novel lactic acid bacterium that has a high capability of producing putrescine and can be utilized as probiotics, and a method for increasing an amount of putrescine production using the lactic acid bacterium.SOLUTION: A lactic acid bacterium herein is Levilactobacillus paucivorans N36 strain (accession number: NITE P-03449) or N50 strain (accession number: NITE P-03450).SELECTED DRAWING: Figure 1
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to a putrescine-producing lactic acid bacterium, a food or drink containing the lactic acid bacterium, and a method for increasing putrescine production. [Background technology]

[0002] Putrescine is a type of polyamine produced in living organisms from the amino acid ornithine, and has the chemical name "1,4-diaminobutane." Its functions include stabilizing and structurally changing nucleic acids through interaction with nucleic acids, promoting nucleic acid synthesis, activating protein synthesis, acetylating histones, promoting phosphorylation of non-histone chromatin proteins, stabilizing cell membranes and enhancing permeability to substances, and activating enzymes affected by divalent metals, as well as having an antioxidant effect on fats and oils. It has been reported that putrescine is also produced in human somatic cells and in intestinal bacteria, but the amount produced decreases with age. Due to these circumstances, in recent years, putrescine has begun to be used as a health food. Putrescine can also be synthesized by chemical synthesis, but since highly toxic hydrogen cyanide is used, there are problems not only with the environmental impact but also with safety. Other methods for producing putrescine have been reported, including a method for extracting and purifying putrescine from fish milt, dairy materials, yeast, plants, or the like that contain a large amount of polyamines, and a method for producing putrescine using a microorganism (e.g., Patent Documents 1 and 2, etc.). However, from the viewpoints of production yield and safety for humans, a new method for producing putrescine is desired.

[0003] On the other hand, lactic acid bacteria are used in the production of dairy products such as yogurt and cheese, and fermented foods such as pickles, miso, and soy sauce, and in recent years have been known as a useful microbial resource deeply related to human health because they have various health-maintaining effects such as intestinal regulation by improving the bacterial flora in the digestive tract, immune enhancement, and antitumor effects as probiotics. However, there is a problem in that lactic acid bacteria ingested as food are exposed to various stresses such as gastric acid and bile acid, which reduces their survival rate in the intestine and their inherent useful effects. [Prior art documents] [Patent documents]

[0004] [Patent Document 1] JP 2006-191808 A [Patent Document 2] JP 2010-057396 A Summary of the Invention [Problem to be solved by the invention]

[0005] An object of the present invention is to provide a novel lactic acid bacterium that has high putrescine productivity and can be used as a probiotic, and to provide a method for increasing putrescine production using the lactic acid bacterium. [Means for solving the problem]

[0006] As a result of intensive research conducted by the present inventors to solve the above-mentioned problems, they discovered that a specific strain of Leviractobacillus paucivorans has the ability to produce putrescine and is also resistant to bile acids, thereby solving the above-mentioned problems.

[0007] Specifically, the present invention relates to the following items. 1. A lactic acid bacterium which is Rebilactobacillus paucivorans strain N36 (accession number: NITE P-03449) or strain N50 (accession number: NITE P-03450). 2. A food or drink containing the lactic acid bacteria described in 1. 3. A method for increasing putrescine production, comprising adding glucose to a skim milk medium in which the lactic acid bacterium described in 1 is cultured. Effect of the Invention

[0008] The specific lactic acid bacteria belonging to the genus Leviractobacillus according to the present invention have the ability to produce putrescine and are resistant to bile acids, and therefore can be used as probiotics. The lactic acid bacteria of the present invention can be cultured in milk such as skim milk and used together with the putrescine produced as a highly safe food or drink, making them extremely useful. Furthermore, when the lactic acid bacterium is cultured in a skim milk medium, the amount of putrescine produced can be increased by adding glucose. [Brief description of the drawings]

[0009] [Figure 1] FIG. 2 shows the 16S rDNA base sequence of the lactic acid bacteria strain N36 of the present invention. [Diagram 2] FIG. 2 shows the 16S rDNA base sequence of the lactic acid bacteria strain N50 of the present invention. [Diagram 3] 1 is a chart showing the analysis results by high performance liquid chromatography in the putrescine production confirmation test in Example 2. [Figure 4] 1 is a graph showing the bile acid resistance (%) of the GG strain, the N36 lactic acid bacteria strain of the present invention, and the N50 strain in the probiotic suitability test of Example 3. [Diagram 5] 1 is a graph showing the amounts of putrescine produced by the lactic acid bacteria strains N36 and N50 of the present invention when no sugar is added and when sugar is added in Test 1 for confirming the amount of putrescine produced during skim milk culture in Example 4. [Figure 6] 1 is a graph showing the amount of putrescine produced when the lactic acid bacteria strains N36 and N50 of the present invention are co-cultured with starter lactic acid bacteria in Test 2 for Confirmation of Putrescine Production in Skim Milk Cultivation in Example 5. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0010] The present invention relates to a lactic acid bacterium, Leviractobacillus paucivorans strain N36 (accession number: NITE P-03449) or strain N50 (accession number: NITE P-03450). The genus Leviractobacillus in the present invention is one of the genera that were reclassified into a total of 25 genera in 2020 as a result of reevaluating the genus classification at the genome level using genome data of the type strains of all species previously classified in the genus Lactobacillus (261 species, as of August 19, 2019). The genus Leviractobacillus included approximately 9.2% (24 species) of all reclassified species. The present invention will be described in detail below.

[0011] <Reviractobacillus paucivorans strain N36, strain N50> Levilactobacillus paucivorans N36 and N50 strains are lactic acid bacteria isolated from "rice bran pickles" and are strains stored in the lactic acid bacteria library of the Livestock Product Function Unit, Livestock Product Research Division, Livestock Research Department, National Agriculture and Food Research Organization. They were identified as Levilactobacillus paucivorans by a homology search using 16S rDNA base sequence. They are a species of lactic acid bacteria belonging to the Lactobacillus genus that has been certified as "Generally Recognized As Safe" (GRAS) in the United States, and are therefore extremely safe for humans. Both the N36 and N50 strains of the present invention have been deposited at the Patent Microorganism Depositary of the National Institute of Technology and Evaluation, with the accession numbers being NITE P-03449 (deposit date: March 19, 2021) for the N36 strain and NITE P-03450 (deposit date: March 19, 2021) for the N50 strain. The strain characteristics of the Lactobacillus paucivorans strains N36 and N50 are as follows. (N36 strain) Cell shape: Bacillus Gram staining: positive Growth temperature: Grows at 20-35°C. Does not grow at 40°C. Motility: None Sugar assimilation: ribose, glucose, fructose, maltose Gas production using glucose as a carbon source:+ Salt tolerance: 6% Bile acid resistance: 0.6% (N50 stock) Cell shape: Bacillus Gram staining: positive Growth temperature: Grows at 20-35°C. Does not grow at 40°C. Motility: None Sugar assimilation: ribose, glucose, fructose, maltose Gas production using glucose as a carbon source:+ Salt tolerance: 6% Bile acid resistance: 0.6%

[0012] <Method of producing putrescine> Putrescine can be produced using the lactic acid bacteria strains N36 and N50 of the present invention. The method for producing putrescine relates to a method for culturing the lactic acid bacteria strains N36 and N50 of the present invention in a medium containing a putrescine-producing substrate.

[0013] (Culture process) The culture medium for producing putrescine using the lactic acid bacteria strains N36 and N50 of the present invention may include a medium containing a putrescine-producing substrate in addition to necessary nutrient sources such as carbon sources, nitrogen sources, or inorganic salts that can be assimilated by lactic acid bacteria belonging to the genus Leviractobacillus. A preferred example of the putrescine-producing substrate is ornithine. The concentration of the putrescine-producing substrate contained in the medium is not particularly limited, but may usually be about 0.01 to 2 weight / volume %, preferably about 0.1 to 1 weight / volume %. Any medium, whether natural or synthetic, may be used as long as it allows lactic acid bacteria to grow, and those skilled in the art can appropriately select a suitable known medium to be used. As the carbon source, glucose, fructose, etc. can be used, and as the nitrogen source, meat extract, peptone, yeast extract, casein hydrolysate, whey protein hydrolysate, soy protein hydrolysate, etc. can be used. Inorganic salts include phosphate, sodium, potassium, magnesium, etc. Examples of media suitable for culturing lactic acid bacteria include M17 medium (with the above carbon source added) and MRS liquid medium. It has been confirmed by the experimental examples described below that the lactic acid bacteria strains N36 and N50 of the present invention increase the amount of putrescine produced by adding glucose to a skim milk medium.

[0014] The culture conditions are not particularly limited as long as they allow the growth of lactic acid bacteria. Although there are no particular limitations on the pH of the medium, it is usually in the range of pH 5 to 8, preferably pH 6 to 7. The medium and culture device can be sterilized at 105 to 121° C. for 15 minutes before use. The culture temperature may be set within the range of growth temperatures for the lactic acid bacteria N36 and N50 strains, preferably within the range of the optimal growth temperatures, for example, 20° C. to 35° C., preferably about 25° C. to 30° C. The culture time is not limited, but may be, for example, about 1 to 6 days. There is no need to block or supply oxygen during cultivation. Therefore, putrescine can be produced by simply covering the culture vessel with a lid. Cultivation methods include stationary culture, shaking culture, and tank culture.

[0015] <Food and beverages> The lactic acid bacteria strains N36 and N50 of the present invention can be used as probiotics by taking advantage of their putrescine-producing ability, and one embodiment of this can be used as food or drink. Examples of foods and beverages in the present invention include beverages such as milk drinks (including concentrated original solutions and powders for adjusting these beverages), dairy products such as processed milk, fermented milk, yogurt, butter, and cheese, and lactic acid bacteria fermented foods such as kimchi and pickled vegetables. They can also be made into medicines or quasi-drugs (supplements), and can be used as formulations such as powders, granules, tablets, capsules, suspensions, liquids, emulsions, and injections. EXAMPLES

[0016] The present invention will be described below with reference to examples, but the technical scope of the present invention is not limited to these examples. <Example 1: Lactic acid bacteria strain selection test> (1) Test specimen To select lactic acid bacteria capable of producing putrescine, a test was first conducted to confirm whether or not they produced amines using a food-derived lactic acid bacteria library of 360 strains from 44 species in the Livestock Functional Unit of the Livestock Research Division, Livestock Products Research Department, National Agriculture and Food Research Organization. (2) Test method The cells were cultured in a lactic acid bacteria growth liquid medium (MRS medium) at 30°C for 24 hours, centrifuged to discard the culture supernatant, and washed with physiological saline. After washing, the cells were added to the following amine production test medium containing ornithine as a putrescine-producing substrate, and cultured at 30°C for 24 hours. [Amine production test medium, pH 5.0] Tryptone 5g / L, yeast extract 5g / L, sodium chloride 5g / L, glucose 1g / L, surfactant (Tween 80) 0.5g / L, magnesium sulfate heptahydrate 0.2g / L, calcium carbonate 0.1g / L, bromocresol purple 0.06g / L, manganese sulfate tetrahydrate 0.05g / L, ferrous sulfate heptahydrate 0.04g / L, and ornithine 10g / L were dissolved in purified water, the pH was adjusted to 5.0 with 1N hydrochloric acid, and the solution was heat sterilized at 121°C for 15 minutes. (3) Judgment of amine production capability This can be confirmed by the presence of bromocresol purple, which turns the medium purple if amines are produced, or yellow if only acids are produced. (4) Results From the results of the above test, it was confirmed that, among the 360 ​​strains of lactic acid bacteria tested, two strains of the lactic acid bacteria of the present invention, N36 and N50, produced amines.

[0017] <Example 2: Putrescine production confirmation test> (1) Test specimen In the above "Example 1: Lactic acid bacteria strain selection test", the amine production medium of the lactic acid bacteria strains N36 and N50, in which the medium turned purple, was used. (2) Test method The test sample (1) above was diluted with 0.1N hydrochloric acid, and then 1,7-diaminoheptane was used as an internal standard substance, and 5-(dimethylamino)naphthalene-1-sulfonyl chloride (dansyl chloride) was added to convert the amino group to dansylated form. This was extracted with ether, and the extract was dissolved in acetonitrile and subjected to high performance liquid chromatography (HPLC) analysis using the following analytical equipment and conditions. (Analysis equipment and conditions) Equipment: Shimadzu Corporation High-performance liquid chromatography (LC-VP series) Pump: LC-10ADvp Column oven: CTO-10ASvp Detector: SPD-M10vp Column: Kromasil C18 (250 x 4.6 mm) Oven temperature: 30℃ Flow rate: 0.8mL / min Mobile phase: Acetonitrile Sample injection volume: 10 μL (3) Results As shown in FIG. 3 below, a putrescine peak was detected in the amine production medium of the lactic acid bacteria strains N36 and N50 of the present invention, confirming that they produce putrescine.

[0018] Example 3: Probiotic compatibility test The lactic acid bacteria strains N36 and N50 of the present invention, which were confirmed to have putrescine production ability, were tested for resistance to bile acids in order to clarify their suitability as probiotics. The lactic acid bacteria used as a control was Lacticaceibacillus rhamnosus GG strain, which is widely used as a probiotic lactic acid bacterium. The GG strain was registered with the American Type Culture Collection (ATCC) (Manassas, VA, USA) under the accession number ATCC 53103. Each strain was precultured overnight in MRS medium at the optimum growth temperature, and then inoculated in 20 μL each into MRS medium without bile and MRS medium with 0.3 and 0.6% bile (4 mL each). The GG strain was cultured at the optimum growth temperature of 37°C for 48 hours, and the N36 and N50 strains were cultured at 30°C for 48 hours. OD620 after the culture was measured, and the OD620 value after the culture in the MRS medium to which bile had been added was set as 100. The values ​​after the culture in the MRS medium to which bile had been added are shown in FIG. Both the N36 and N50 strains grew better in bile-supplemented medium than the GG strain, confirming that they have bile acid resistance and are expected to be effective as probiotics.

[0019] <Example 4: Test 1 to confirm the amount of putrescine produced during skim milk culture> The lactic acid bacteria strains N36 and N50 of the present invention, which were confirmed to have the ability to produce putrescine, were tested to confirm the amount of putrescine produced during skim milk culture. The amount of putrescine produced by adding sugar during skim milk culture was also confirmed. Each strain was precultured overnight in MRS medium (30°C), the cells were washed, and the washed cells were then diluted with 10 x 10 9The lactic acid bacteria were resuspended in 10% skim milk medium (sugar-free) or 10% skim milk medium (sweetened) to which 0.5% glucose was added, so that the concentration of cfu / mL was reached. cfu stands for colony forming unit. The skim milk medium inoculated with each lactic acid bacterium was cultured at 30, 35, and 40°C for 24 to 48 hours. The culture solution was thoroughly stirred with a vortex and diluted with 1N hydrochloric acid, after which 1,7-diaminoheptane was used as an internal standard substance, and then 5-(dimethylamino)naphthalene-1-sulfonyl chloride (dansyl chloride) was added to dansylate the amino group. This was extracted with ether, and the extract was dissolved in acetonitrile and analyzed by high performance liquid chromatography (HPLC), with the results shown in Figure 5. Both strains N36 and N50 were shown to produce putrescine in 10% skim milk medium at a culture temperature of 30-40°C. The addition of 0.5% glucose increased the putrescine concentration in the medium by 1.5-fold.

[0020] <Example 5: Test 2 to confirm the amount of putrescine produced during skim milk culture> A test was carried out to confirm the amount of putrescine produced by culturing the lactic acid bacteria strains N36 and N50 of the present invention in skim milk in the presence of a commercially available yogurt starter strain. Each strain was precultured overnight in MRS medium (30°C), the cells were washed, and the washed cells were then diluted with 10 x 10 7 The bacteria were resuspended in 10% skim milk medium to a concentration of cfu / mL. Commercially available yogurt starter bacteria were inoculated into 10% skim milk medium, cultured at 37°C for 16 hours, and added at 1%. The skim milk medium inoculated with each lactic acid bacteria and yogurt starter bacteria was cultured at 37°C for 6 to 168 hours. The culture solution was thoroughly stirred with a vortex and diluted with 1N hydrochloric acid, and then 1,7-diaminoheptane was used as an internal standard substance, and 5-(dimethylamino)naphthalene-1-sulfonyl chloride (dansyl chloride) was added to dansylate the amino group. This was extracted with ether, and the extract was dissolved in acetonitrile and analyzed by high performance liquid chromatography (HPLC), and the results are shown in Figure 6. The commercial yogurt starter did not produce putrescine in skim milk medium, but both strains N36 and N50 were shown to produce putrescine in the presence of yogurt starter bacteria. [Industrial Applicability]

[0021] The specific lactic acid bacteria belonging to the genus Leviractobacillus of the present invention can be used as a probiotic because it has the ability to produce putrescine and is resistant to bile acids. In addition, when the lactic acid bacteria is cultured in a skim milk medium, the amount of putrescine produced can be increased by adding glucose. Furthermore, the lactic acid bacteria of the present invention can be cultured in milk such as skim milk and used together with the produced putrescine as a highly safe food or drink, making them extremely useful.

Claims

1. A lactic acid bacterium which is a Reviractobacillus paucivorans N36 strain (accession number: NITE P-03449) or N50 strain (accession number: NITE P-03450).

2. A food or drink comprising the lactic acid bacteria according to claim 1.

3. A method for increasing putrescine production, which comprises adding glucose to a skim milk medium in which the lactic acid bacterium according to claim 1 is cultured.

Citation Information

Patent Citations

  • Capsule including live cell or tissue

    JP2001245660A

  • Microorganism having productivity of putrescine and method for producing putrescine using the same

    JP2006191808A

  • New microorganism having putrescine synthesis ability, putrescine synthesis gene and production method of putrescine

    JP2010057396A

  • Novel microorganism having ability to produce putrescine, and production method of putrescine using the same

    JP2016073260A

  • Fermented soymilk extract and fermented hypocotyl extract

    WO2014091988A1